Subscribe


Pharmacy Daily

PD breaking news – Codeine to be upscheduled from 2018

Guild slams reported decision as failing consumers. 

The Pharmacy Guild has just issued a statement decrying a decision by the Therapeutic Goods Administration to make codeine-containing medicines prescription-only from 2018.

Although there’s no formal confirmation of the move from the TGA at this stage, News Limited reported the story overnight, saying it’s understood the move will become effective after 12 months to allow time for people with chronic pain to make alternative arrangements with their doctor.

Guild National President, George Tambassis, said the move was “short-sighted and ultimately would only add pressure to the already financially stressed health system, while also increasing the burden on already over-worked doctors”.

“Making these medicines schedule 4 will simply create a barrier to the majority of consumers who use these products safely,” Tambassis said, saying the reported decision came despite the success of the MedsASSIST real-time recording system.

“As custodians of Australia’s medicines schedule, pharmacists will comply with the decision and ensure they are available to advise and counsel patients, many of whom will be disappointed and annoyed that their safe access to these medicines has been denied,” Mr Tambassis said.

More details in today’s issue of Pharmacy Daily.

 


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 20 Dec 16

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

21 Sep

Travel Specials 21 Sep 17 - Fly Free with Voyages to Antiquity Grand ...


21 Sep

Dispensary Corner 21 Sep 17 - AN INDIANA food processing plant accidently turned ...


21 Sep

Pfizer sues J&J - ON WEDNESDAY, Pfizer filed a complaint in ...


21 Sep

Singulair queried - MERCK Sharp & Dohme's asthma medication Singulair ...


21 Sep

AIHW recruiting - THE Australian Institute of Health and Welfare ...


21 Sep

Dementia publication fires up neurons - UNIVERSITY of Queensland experts are keeping people ...


21 Sep

Online medicine risks - THE Royal Australian College of General Practitioners ...


21 Sep

Antibiotic paucity - THE World Health Organization has reiterated its ...


21 Sep

Pharmacist-led digital care outcomes - PHARMACIST-LED digital healthcare can improve anti-hypertensive medication ...


21 Sep

Indication extensions - THE Therapeutic Goods Administration has posted broadened ...


21 Sep

S4 to S3 switch plans - WHILE it is understood that the individual ...


21 Sep

Lax-Sachets recall - AFT Pharmaceuticals, in consultation with the TGA, ...


21 Sep

APC Council ‘renewal’ - THE president of the Australian Pharmacy Council ...


21 Sep

TGA labeling rules update - TO REDUCE medication errors, medicine labels need ...


20 Sep

Dermal Therapy Very Dry Skin Lotion - DERMAL Therapy Very Dry Skin Lotion is ...


20 Sep

Sensitive SPF 50+ Sunscreen - TO cater for those with sensitive skin, ...


20 Sep

Clinical Protection Anti-Perspirant Deodorant by Dove - DOVE Clinical Protection Anti-Perspirant Deodorant combines clinical ...


20 Sep

Hello Brows 2-in-1 Stylus by Ulta3 - ULTA3 Hello Brows 2-in-1 Stylus is a ...


20 Sep

Dispensary Corner 20 Sep 17 - TALK about flush with cash - Geneva ...


20 Sep

Medlab 20 year patent - AUSTRALIAN-LISTED medical life science company Medlab Clinical ...



Show Pharmacy Daily items by month: